Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

93.86 -2.59 (-2.69%)
Official Closing Price Updated: 4:15 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
34 35 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
US Stocks Show Tentativeness On Tuesday As Traders Wait On Word From Fed Chair Jerome Powell
U.S. stocks look set to start Tuesday’s session on a nervous note as traders may prefer to wait and watch the inflation data before making their next moves. 
Via Benzinga
QIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics
 
Via Benzinga
What Does Illumina's Debt Look Like?
Shares of Illumina Inc. (NASDAQ:ILMN) moved higher by 1.43% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What 7 Analyst Ratings Have To Say About Illumina
 
Via Benzinga
Looking Into Illumina's Return On Invested Capital
 
Via Benzinga
What 12 Analyst Ratings Have To Say About Illumina
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
 
Via Benzinga
Is Illumina Cheap or Expensive?
It depends on which numbers you focus on. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
 
Via Benzinga
Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory
The modern laboratory complex, complete with genomic sequencers and microarray analysis platforms from the U.S. company Illumina, helps solve problems in medical research and agriculture. In addition... 
Via PRUnderground
Topics Economy
11 Analysts Have This to Say About Illumina
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: 
Via Benzinga
This Growth Stock Rose Last Week. Is It Still a Buy?
Illumina is the dominant player in gene sequencing. 
Via The Motley Fool
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection
From GRAIL, LLC
Via Business Wire
Elon Musk' Lost Millions' Over $8 'Blue Check' Fixation, FTX Hacker Holds $339M In Crypto, Amazon To Cut Workforce Starting This Week: Top Stories Tuesday, Nov. 15
Reuters 
Via Benzinga
Illumina Slashes 5% Of Its Workforce
Illumina Inc (NASDAQ: ILMN) is cutting 5% of its global workforce to realign its operating expenses to reflect the current macroeconomic environment. 
Via Benzinga
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
Rosenblatt boosted the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $118 to $103. Rosenblatt analyst Barton Crockett maintained the stock with a Neutral rating. Amazon shares fell 4.3% to close... 
Via Benzinga
$1000 Invested In Illumina 15 Years Ago Would Be Worth This Much Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 15 years by 8.91% on an annualized basis producing an average annual return of 15.72%. Currently, Illumina has a market capitalization... 
Via Benzinga
Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review
A mixed jobs report and heavy earnings swung stocks. 
Via Investor's Business Daily
Musk Reportedly Suspends Twitter Work On Crypto Wallet, Boeing's Jeppesen Hit By Potential Ransomware Attack, Lyft Cuts Workforce: Top Stories Friday, Nov. 04
Reuters 
Via Benzinga
Illumina's Q3 Profits Hit By Impairment Of Almost $4B, Cuts Annual Guidance
 
Via Benzinga
Illumina Plummets On Light Earnings Guidance Despite Quarterly Beat
Illumina posted a wide miss for its full-year adjusted earnings outlook, leading shares to tumble after hours. 
Via Investor's Business Daily
$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 18.98% on an annualized basis producing an average annual return of 26.53%. Currently, Illumina has a market capitalization... 
Via Benzinga
Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest
Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point. 
Via InvestorPlace
Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy?
Bionano's stock price movements have little to do with its successes. 
Via The Motley Fool
Illumina Gains But Lags Market: What You Should Know
In the latest trading session, Illumina (ILMN) closed at $220.57, marking a +0.25% move from the previous day. This move lagged the S&P 500's daily gain of 1.19%. Meanwhile, the Dow gained 1.34%, and... 
Via Talk Markets
Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –
This press release was orginally distributed by SBWire 
Via ReleaseWire
Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –
London, UK -- (SBWIRE) -- 10/18/2022 -- The latest publication titled Companion Diagnostics – Thematic Research has been added to GlobalData Plc report store. Companion diagnostics (CDx) are molecular... 
Via SBWire
Universal Sequencing Technology Corporation Announces High-Throughput Solution For NGS Library Preparation
UST releases high-throughput solution enabling second-generation short-read sequencers to produce long-range results in greater capacity.CARLSBAD, Calif. - Oct. 24, 2022 - PRLog -- Universal Sequencing... 
Via PRLog
Topics Intellectual Property
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.